Did Andrew Garbarino buy Oramed Pharmaceuticals stock?

Common questions

Did Andrew Garbarino buy Oramed Pharmaceuticals stock?

Yes. Andrew Garbarino disclosed 1 purchase and 2 sales of Oramed Pharmaceuticals (ORMP) stock between Apr 23, 2021 and Jan 14, 2022, in STOCK Act reports. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $2K-$30K.

How big were Andrew Garbarino's Oramed Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $2K-$30K.

Did Andrew Garbarino make these Oramed Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Andrew Garbarino still own Oramed Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Andrew Garbarino report these trades?

The latest filing is dated Jan 14, 2022. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.